Prostate cancer: open trials in Singapore

15 open trials have a site in Singapore. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
National Cancer Centre Singapore ( Site 1377), Singapore · National University Hospital ( Site 1376), Singapore · Tan Tock Seng Hospital-Medical Oncology ( Site 1378), Singapore
Registry updated 2026-11-05
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
National Cancer Centre Singapore ( Site 0760), Singapore · Tan Tock Seng Hospital ( Site 0761), Singapore
Registry updated 2026-10-30
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
National Cancer Centre Singapore NCCS, Singapore · National University Hospital (NUH), Singapore
Registry updated 2026-10-30
NCT07288359
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Singapore
Registry updated 2026-10-29
NCT05946213
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Trial Treatment · Phase 3 · NRG Oncology
National Cancer Centre Singapore, Singapore
Registry updated 2026-10-23
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Singapore
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Singapore General Hospital ( Site 1204), Singapore · National University Hospital ( Site 1201), Singapore · Tan Tock Seng Hospital-Medical Oncology ( Site 1203), Singapore · National Cancer Centre Singapore ( Site 1202), Singapore
Registry updated 2026-10-20
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen
National Cancer Centre Singapore, Singapore · Tan Tock Seng Hospital, Singapore · National University Hospital, Singapore
Registry updated 2026-10-20
NCT06855277
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Singapore
Registry updated 2026-10-15
NCT07206056
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Singapore
Registry updated 2026-10-09
NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Trial Treatment · Phase 1/2 · PMV Pharmaceuticals, Inc
National University Hospital, Kent Ridge · National Cancer Center of Singapore, Singapore
Registry updated 2026-10-02
NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Trial Treatment · Phase 2/3 · Novartis Pharmaceuticals
Singapore
Registry updated 2026-09-22
NCT07282808
Focal or Radical Therapy: a Lesion-based Molecular Evaluation in Prostate Cancer
Trial Treatment · Singapore General Hospital
Singapore General Hospital, Singapore
Registry updated 2026-01-08
NCT04340024
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Research · National Cancer Centre, Singapore
National Cancer Center Singapore, Singapore
Registry updated 2025-06-11
NCT06491056
Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
Research · Singapore General Hospital
Singapore General Hospital, Singapore
Registry updated 2024-07-08

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error